Search

Search Constraints

You searched for: Author/Creator Tsujimura, Hideki

Search Results

1. A Host‐Dependent Prognostic Model for Elderly Patients with Diffuse Large B‐Cell Lymphoma. (13th April 2017)

2. A Host‐Dependent Prognostic Model for Elderly Patients with Diffuse Large B‐Cell Lymphoma. (May 2017)

3. Consolidation with 90Yttrium‐ibritumomab tiuxetan after bendamustine and rituximab for relapsed follicular lymphoma. Issue 1 (7th October 2020)

4. Final analysis of randomized phase II study optimizing melphalan, prednisolone, bortezomib in multiple myeloma (JCOG1105). Issue 9 (31st July 2022)

5. Genetic subtype classification using a simplified algorithm and mutational characteristics of diffuse large B‐cell lymphoma in a Japanese cohort. (10th August 2021)

6. HLA genotyping in Japanese patients with multiple myeloma receiving bortezomib: An exploratory biomarker study of JCOG1105 (JCOG1105A1). Issue 12 (26th October 2021)

7. Maxillary Swelling as the First Evidence of Multiple Myeloma. (12th November 2015)

8. Prophylactic antiviral therapy for hepatitis B virus surface antigen‐positive patients with diffuse large B‐cell lymphoma treated with rituximab‐containing chemotherapy. Issue 5 (18th March 2021)

9. Randomised phase II study to optimise melphalan, prednisolone, and bortezomib in untreated multiple myeloma (JCOG1105). (24th June 2020)

10. Randomized phase II study of a bendamustine monotherapy schedule for relapsed or refractory low-grade B-cell non-Hodgkin lymphoma or mantle cell lymphoma (RABBIT-14). Issue 7 (3rd July 2018)